Gene and cell therapy manufacturing: how to design your stable cell line strategy? 

To achieve widespread  uptake of gene and cell therapy, the viral vectors industry needs to solve several challenges to obtain cost-efficient manufacturing processes, like scalability of transfection and infection processes. 

Discover, in this article, a comparison between the different cell lines strategies for gene and cell therapy manufacturing.


Viral Vectored Gene therapies approved worldwide